The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients
Open accessAbstract
BACKGROUND: A frequent complication of anticancer treatment, oral and gastrointestinal (GI) mucositis, threatens the effectiveness of therapy because it leads to dose reductions, increases healthcare costs, and impairs patients' quality of life. The Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology assembled an international multidisciplinary panel of experts to create clinical practice guidelines for the prevention, evaluation, and treatment of mucositis. METHODS: The panelists examined medical literature published from January 1966 through May 2002, presented their findings at two separate conferences, and then created a writing committee that produced two articles: the current study and another that codifies the clinical implications of the panel's findings in practice guidelines. RESULTS: New evidence supports the view that oral mucositis is a complex process involving all the tissues and cellular elements of the mucosa. Other findings suggest that some aspects of mucositis risk may be determined genetically. GI proapoptotic and antiapoptotic gene levels change along the GI tract, perhaps explaining differences in the frequency with which mucositis occurs at different sites. Studies of mucositis incidence in clinical trials by quality and using meta-analysis techniques produced estimates of incidence that are presented herein for what to our knowledge may be a broader range of cancers than ever presented before. CONCLUSIONS: Understanding the pathobiology of mucositis, its incidence, and scoring are essential for progress in research and care directed at this common side-effect of anticancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Coiffier, B., Lepage, E., Brière, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011795 · Cited by 5,574
Goycoolea, A. (1997) · Cited by 3,615
Bone marrow transplant: Angela Joyce on the care of children undergoing BMT for genetic disorders
Joyce, A. (1989) · Paediatric Nursing · doi:10.7748/paed.1.6.21.s21 · Cited by 3,384
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
Saltz, L. B., Cox, J. V., Blanke, C., Rosen, L. S., Fehrenbacher, L., Moore, M. J., Maroun, J. A., Ackland, S. P., Locker, P. K., Pirotta, N., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431302 · Cited by 3,005
Cobleigh, M. A., Vogel, C. L., Tripathy, D., Robert, N. J., Scholl, S., Fehrenbacher, L., Wolter, J. M., Paton, V., Shak, S., Lieberman, G., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2639 · Cited by 2,765
TAN, P. (2001) · A Clinical Approach to Medicine · doi:10.1142/9789810248178_0024 · Cited by 2,697
WHO Handbook for Reporting Results of Cancer Treatment
Palmer, M. K. (1982) · British Journal of Cancer · doi:10.1038/bjc.1982.83 · Cited by 2,198
Cited by
Stewart, F. A., Akleyev, A. V., Hauer-Jensen, M., Hendry, J. H., Kleiman, N. J., MacVittie, T. J., Aleman, B. M., Edgar, A. B., Mabuchi, K., Muirhead, C. R., et al. (2012) · Annals of the ICRP · doi:10.1016/j.icrp.2012.02.001 · Cited by 1,604
Self-citationMASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
Elad, S., Cheng, K. K. F., Lalla, R. V., Yarom, N., Hong, C., Logan, R. M., Bowen, J., Gibson, R., Saunders, D. P., Zadik, Y., et al. (2020) · Cancer · doi:10.1002/cncr.33100 · Cited by 1,336
Photopharmacology: Beyond Proof of Principle
Velema, W. A., Szymanski, W., & Feringa, B. L. (2014) · Journal of the American Chemical Society · doi:10.1021/ja413063e · Cited by 1,178
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
Lalla, R. V., Bowen, J., Barasch, A., Elting, L., Epstein, J., Keefe, D. M., McGuire, D. B., Migliorati, C., Nicolatou‐Galitis, O., Peterson, D. E., et al. (2014) · Cancer · doi:10.1002/cncr.28592 · Cited by 1,110
Self-citationRubenstein, E. B., Peterson, D. E., Schubert, M., Keefe, D., McGuire, D., Epstein, J., Elting, L. S., Fox, P. C., Cooksley, C., Sonis, S. T., et al. (2004) · Cancer · doi:10.1002/cncr.20163 · Cited by 820
Self-citationUpdated clinical practice guidelines for the prevention and treatment of mucositis
Keefe, D. M., Schubert, M. M., Elting, L. S., Sonis, S. T., Epstein, J. B., Raber‐Durlacher, J. E., Migliorati, C. A., McGuire, D. B., Hutchins, R. D., & Peterson, D. E. (2007) · Cancer · doi:10.1002/cncr.22484 · Cited by 784
Self-citationInterventions for treating oral mucositis for patients with cancer receiving treatment
Clarkson, J. E., Worthington, H. V., Furness, S., McCabe, M., Khalid, T., & Meyer, S. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001973.pub4 · Cited by 674
Management of Oral Mucositis in Patients Who Have Cancer
Lalla, R. V., Sonis, S. T., & Peterson, D. E. (2008) · Dental Clinics of North America · doi:10.1016/j.cden.2007.10.002 · Cited by 602
Self-citationHensley, M. L., Hagerty, K. L., Kewalramani, T., Green, D. M., Meropol, N. J., Wasserman, T. H., Cohen, G. I., Emami, B., Gradishar, W. J., Mitchell, R. B., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.2627 · Cited by 540
Elting, L. S., Cooksley, C. D., Chambers, M. S., & Garden, A. S. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.01.053 · Cited by 533
Self-citationOral complications of cancer and cancer therapy: From cancer treatment to survivorship
Epstein, J. B., Thariat, J., Bensadoun, R., Barasch, A., Murphy, B. A., Kolnick, L., Popplewell, L., & Maghami, E. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21157 · Cited by 518
Radiation-Induced Oral Mucositis
Maria, O. M., Eliopoulos, N., & Muanza, T. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00089 · Cited by 455
Elting, L. S., Keefe, D. M., Sonis, S. T., Garden, A. S., Spijkervet, F. K. L., Barasch, A., Tishler, R. B., Canty, T. P., Kudrimoti, M. K., Vera‐Llonch, M., et al. (2008) · Cancer · doi:10.1002/cncr.23898 · Cited by 373
Self-citationManagement of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines
Peterson, D. E., Bensadoun, R.-J., & Roila, F. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr391 · Cited by 305
Self-citationNew Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury
Cinausero, M., Aprile, G., Ermacora, P., Basile, D., Vitale, M. G., Fanotto, V., Parisi, G., Calvetti, L., & Sonis, S. T. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00354 · Cited by 290
Self-citationRole of antioxidants in cancer therapy
Fuchs-Tarlovsky, V. (2013) · Nutrition · doi:10.1016/j.nut.2012.02.014 · Cited by 282
Logan, R. M., Stringer, A. M., Bowen, J. M., Yeoh, A. S.-J., Gibson, R. J., Sonis, S. T., & Keefe, D. M. K. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.03.001 · Cited by 279
Self-citationMurphy, B. A., & Gilbert, J. (2009) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2008.09.007 · Cited by 273
Interventions for preventing oral mucositis for patients with cancer receiving treatment
Worthington, H. V., Clarkson, J. E., Bryan, G., Furness, S., Glenny, A.-M., Littlewood, A., McCabe, M. G., Meyer, S., Khalid, T., & Riley, P. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000978.pub5 · Cited by 262
Systematic review of basic oral care for the management of oral mucositis in cancer patients
On behalf of the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO), McGuire, D. B., Fulton, J. S., Park, J., Brown, C. G., Correa, M. E. P., Eilers, J., Elad, S., Gibson, F., Oberle-Edwards, L. K., et al. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-013-1942-0 · Cited by 256
Scully, C., Sonis, S., & Diz, P. (2006) · Oral Diseases · doi:10.1111/j.1601-0825.2006.01258.x · Cited by 253
Self-citationGastro-intestinal toxicity of chemotherapeutics in colorectal cancer: The role of inflammation
Lee, C. S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i14.3751 · Cited by 224
Chang (2018) · doi:10.3389/fmicb.2018.00983 · Cited by 152
Fijlstra, M., Ferdous, M., Koning, A. M., Rings, E. H. H. M., Harmsen, H. J. M., & Tissing, W. J. E. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-014-2487-6 · Cited by 97
Topuz, E., Derin, D., Can, G., Kürklü, E., Çınar, S., Aykan, F., Çevikbaş, A., Dişçi, R., Durna, Z., Şakar, B., et al. (2008) · Investigational New Drugs · doi:10.1007/s10637-008-9171-y · Cited by 49
de Freitas Cuba, L., Braga Filho, A., Cherubini, K., Salum, F. G., & Figueiredo, M. A. Z. D. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-015-3048-3 · Cited by 32
Zheng, Y., Ke, L., Lu, Y., Zuo, Q., Deng, G., Wang, H., & Zeng, X. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00273 · Cited by 11
Metadata
- Authors
- Sonis, S. T., Elting, L. S., Keefe, D., Peterson, D. E., Schubert, M., Hauer-Jensen, M., Bekele, B. N., Raber-Durlacher, J., Donnelly, J. P., Rubenstein, E. B., & for the Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2004
- Volume
- 100
- Issue
- S9
- Pages
- 1995-2025
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1978454448
- Cited by
- 1,417
- References
- 115
- FWCI
- 40.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.